Digest Network Come funziona
Network
/
Società
Be
Non verificato

Be Biopharma, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

11 comunicati stampa

Guarda tutti i comunicati
30/07/2025
Salute
Scienza
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Be Bio Announces First Participant Dosed in BeCoMe-9 Trial of BE-101 in Hemophilia B
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
17/05/2025
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Be Biopharma Announces New Preclinical Data for BE-102, a B Cell Medicine for the Potential Treatment of Hypophosphatasia
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
28/04/2025
Eventi
Biologia
Biotecnologia
Sanità
Salute
Farmaceutica
Scienza
Medicina - Varie
Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
03/03/2025
Scienza
Biotecnologia
Farmaceutica
Oncologia
Sanità
Salute
Mercato del lavoro
Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
06/02/2025
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Industria
Be Biopharma Announces Publication of Manuscript in the Molecular Therapy Journal Demonstrating In Vivo Engraftment and Tracking of Ex-vivo-Generated Plasma Cells in Non-Human Primates
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
15/01/2025
Scienza
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Salute
Oncologia
Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
07/01/2025
Eventi
Scienza
Biotecnologia
Medicina - Varie
Sanità
Salute
Farmaceutica
Oncologia
Be Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
09/12/2024
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Oncologia
Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
05/11/2024
Web e Social Network
Eventi
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Be Biopharma Announces Upcoming Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0
22/10/2024
Mercato del lavoro
Eventi
Industria
Attrezzature medico-sanitarie
Sanità
Associazioni/Professionisti
HIV, AIDS e malattie autoimmuni
Scienza
Fitness
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Biologia
Oncologia
Be Bio Announces $82 Million Financing and Transition to Clinical Stage Company
Fonte
Be Biopharma, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0